speb/financial-data huggingface dataset:
Stock screener scorecard for AUB.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3612210432 (Mid Cap ($2B-$10B))
P/E ratio: 13.97718507692932
Debt to equity: 0.6517000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BLUEDART.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.4304204953225095 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.9471347028127295%
Earnings yield: 0.6791760831332917%
Return on net tangible assets: 2.8124334313990778%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.375634830376608%
Revenue growth: -9.731916222351796%
Rule of 40 score: -9.731916222351796
Market cap: 116539744256 (Large Cap ($10B-$200B))
P/E ratio: 0.4810257970882202
Debt to equity: 0.6426613688422641
Operating income: 8713437.897414159
Net income: 5176981.771937261
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BLUEDART.NS (annual, report date 2026-03-31)
Altman Z-score: 4.812572499878042 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 19.898897279443887%
Earnings yield: 3.423966023580021%
Return on net tangible assets: 27.127172655202%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.01776498651306%
Free cash flow margin: 8.050800536730893%
Revenue growth: -2.679971069782162%
Rule of 40 score: 5.370829466948731
Market cap: 116539744256 (Large Cap ($10B-$200B))
P/E ratio: 0.4810257970882202
Debt to equity: 0.6426613688422641
Free cash flow (dilution adjusted): 52394022.89105553
Operating income: 43927511.65748198
Net income: 26217676.98177194
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for CARTRADE.NS (annual, report date 2026-03-31)
Altman Z-score: 20.599537534710084 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 18.566034757727234%
Earnings yield: 0.01938109748114161%
Return on net tangible assets: 22.076387647840985%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.9339174438313425%
Free cash flow margin: 27.571993277787133%
Revenue growth: 10.128559496165535%
Rule of 40 score: 37.700552773952666
Market cap: 128374603776 (Large Cap ($10B-$200B))
P/E ratio: 0.38954432804335287
Debt to equity: 0.0536
Free cash flow (dilution adjusted): 22770188.63925392
Operating income: 23136138.194150064
Net income: 25806263.24713862
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CARTRADE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 20.235275620090302 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 5.164971766883593%
Earnings yield: 0.005391717865854587%
Return on net tangible assets: 7.055326771280855%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.2071734828094507%
Revenue growth: -7.82665573718917%
Rule of 40 score: -7.82665573718917
Market cap: 128374603776 (Large Cap ($10B-$200B))
P/E ratio: 0.38954432804335287
Debt to equity: 0.0536
Operating income: 6436350.148367953
Net income: 7508033.0648579905
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CHKP (quarterly, report date 2026-03-31)
Altman Z-score: 8.486312431051562 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 10.078405749754982%
Earnings yield: 0.4549454488797449%
Return on net tangible assets: 33.070995245122155%
Capitalized R&D asset: 72681976.23392406
ROCI (R&D adjusted): 2.981756890275447%
Rosenberg metric: -0.5839740521604532
Free cash flow margin: 56.26870137642131%
Revenue growth: -9.70192243967842%
Rule of 40 score: 46.56677893674289
Market cap: 13331279872 (Large Cap ($10B-$200B))
P/E ratio: 14.711637487126671
Debt to equity: 0.7012
Free cash flow (dilution adjusted): 119018987.34177217
Operating income: 58575949.36708861
Net income: 60632911.39240506
Long score: 10 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ETD (quarterly, report date 2026-03-31)
Altman Z-score: 3.350076871252661 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.5007125241000798%
Earnings yield: 1.1431760385839171%
Return on net tangible assets: 1.5868905994868208%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.1839252089228596%
Free cash flow margin: 8.703206095630728%
Revenue growth: -9.392593185517223%
Rule of 40 score: -0.6893870898864947
Market cap: 580685440 (Small Cap ($300M-$2B))
P/E ratio: 13.803797468354428
Debt to equity: 0.2554
Free cash flow (dilution adjusted): 11822000
Operating income: 6803000
Net income: 5934000
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PRICOLLTD.NS (annual, report date 2026-03-31)
Altman Z-score: 6.158082593290418 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 29.23643617856806%
Earnings yield: 0.04983430453522343%
Return on net tangible assets: 4.459042067255403%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 26.49635919738631%
Free cash flow margin: -1.0626032771169442%
Revenue growth: 37.10282938287218%
Rule of 40 score: 36.04022610575524
Market cap: 76626894848 (Large Cap ($10B-$200B))
P/E ratio: 0.26371741070658816
Debt to equity: 0.30219999999999997
Free cash flow (dilution adjusted): -4463755.828740992
Operating income: 39449978.804578215
Net income: 26579058.923272572
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for PRICOLLTD.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.629120851279349 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 7.847695642612547%
Earnings yield: 0.01337661171030094%
Return on net tangible assets: 9.07556444947144%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.1121993579659915%
Revenue growth: 0.50052715603902%
Rule of 40 score: 0.50052715603902
Market cap: 76626894848 (Large Cap ($10B-$200B))
P/E ratio: 0.26371741070658816
Debt to equity: 0.30219999999999997
Operating income: 10589232.725731242
Net income: 7760703.688003391
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for QGEN (quarterly, report date 2026-03-31)
Altman Z-score: 2.868074786422307 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 5.902325635535213%
Earnings yield: 1.4032047974965294%
Return on net tangible assets: 26.980446250489305%
Capitalized R&D asset: 111630402.02839756
ROCI (R&D adjusted): 2.1490977836345193%
Rosenberg metric: -0.48233958600248944
Free cash flow margin: 8.631987325316867%
Revenue growth: -10.99472653666136%
Rule of 40 score: -2.3627392113444934
Market cap: 8532562432 (Mid Cap ($2B-$10B))
P/E ratio: 20.244897959183675
Debt to equity: 0.5004
Free cash flow (dilution adjusted): 48847126.43678161
Operating income: 134052873.56321838
Net income: 78210344.8275862
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for SAM (quarterly, report date 2026-06-30)
Altman Z-score: 2.729433819647782 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 8.575022097574916%
Earnings yield: 3.2623183766458%
Return on net tangible assets: 10.555721805840825%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.777268423741122%
Free cash flow margin: 20.139792713206102%
Revenue growth: 31.66997417543373%
Rule of 40 score: 51.80976688863983
Market cap: 1875981568 (Small Cap ($300M-$2B))
P/E ratio: 7.162495381057653
Debt to equity: 0.044199999999999996
Free cash flow (dilution adjusted): 122401000
Operating income: 51611000
Net income: 51567000
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for SFZN.SW (annual, report date 2025-12-31)
Altman Z-score: 3.6950948011897946 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 14.042324689272212%
Earnings yield: 7.672254891393192%
Return on net tangible assets: 4.861529949858534%
Capitalized R&D asset: 106549382.61000603
ROCI (R&D adjusted): 12.905597091373874%
Rosenberg metric: 1.8053582341595114
Free cash flow margin: -0.8364750413078744%
Revenue growth: 16.851060425407656%
Rule of 40 score: 16.01458538409978
Market cap: 3097256448 (Mid Cap ($2B-$10B))
P/E ratio: 24.465981012658226
Debt to equity: 0.5101
Free cash flow (dilution adjusted): -14059493.670886075
Operating income: 273753164.556962
Net income: 213492405.06329113
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SLCE3.SA (quarterly, report date 2026-03-31)
Altman Z-score: 0.8369866208950325 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.341109074816907%
Earnings yield: 0.6886922880361256%
Return on net tangible assets: -9.005361341191545%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.9196516389329368%
Free cash flow margin: -49.310167954375665%
Revenue growth: 21.211856923330203%
Rule of 40 score: -28.098311031045462
Market cap: 6958284800 (Mid Cap ($2B-$10B))
P/E ratio: 5.472360339280492
Debt to equity: 1.7675
Free cash flow (dilution adjusted): -249838403.04182512
Operating income: 118797338.40304182
Net income: 44882509.50570343
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SXI (quarterly, report date 2026-03-31)
Altman Z-score: 4.617127479251314 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 7.55509300621572%
Earnings yield: 0.953706190112342%
Return on net tangible assets: -200.04698858453798%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.885984220665141%
Free cash flow margin: 1.9666510830606203%
Revenue growth: 1.479757816735948%
Rule of 40 score: 3.4464088997965683
Market cap: 3678695936 (Mid Cap ($2B-$10B))
P/E ratio: 30.92831105710814
Debt to equity: 0.6537000000000001
Free cash flow (dilution adjusted): 4417000
Operating income: 39491000
Net income: 68517000
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ZDC.V (quarterly, report date 2026-03-31)
Altman Z-score: 4.83354360006334 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.8159557784575252%
Earnings yield: 0.12206276269746184%
Return on net tangible assets: -15.614757633258582%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7687693838141494%
Free cash flow margin: -92.42424242424244%
Revenue growth: 6.950037777629389%
Rule of 40 score: -85.47420464661305
Market cap: 571277824 (Small Cap ($300M-$2B))
P/E ratio: 350.35971223021585
Debt to equity: 0.5379999999999999
Free cash flow (dilution adjusted): -12902158.273381297
Operating income: 756115.1079136691
Net income: -200000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 2216.T (annual, report date 2025-12-31)
Altman Z-score: 5.082422774917166 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 24.235300170984292%
Earnings yield: 0.06006823408566274%
Return on net tangible assets: -0.9421682953383868%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 21.97045100440425%
Free cash flow margin: -0.6475816960908212%
Revenue growth: 9.82547510166809%
Rule of 40 score: 9.177893405577269
Market cap: 69124318784.11748 (Large Cap ($10B-$200B))
P/E ratio: 20.458202786994782
Debt to equity: 0.0565006450384084
Free cash flow (dilution adjusted): -1439652.1961511413
Operating income: 29993657.694520812
Net income: 21602244.102039512
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2880.HK (annual, report date 2025-12-31)
Altman Z-score: 0.7889315538887596 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 5.654319851135097%
Earnings yield: 1.5401498833811684%
Return on net tangible assets: 10.447545758464475%
Capitalized R&D asset: 7207565.787548705
ROCI (R&D adjusted): 4.603499502670426%
Rosenberg metric: 49.956804525914585
Free cash flow margin: 45.669949192440356%
Revenue growth: 7.039424706902872%
Rule of 40 score: 52.70937389934323
Market cap: 3527553870.781491 (Mid Cap ($2B-$10B))
P/E ratio: 2.2008894814233346
Debt to equity: 0.2314901561887459
Free cash flow (dilution adjusted): 741086975.8928572
Operating income: 361422995.84999996
Net income: 228969365.11714286
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2932.T (annual, report date 2025-12-31)
Altman Z-score: 3.9769225297668043 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 19.122257053291534%
Earnings yield: 0.08128681393624175%
Return on net tangible assets: 30.207384926656555%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.353020861555134%
Free cash flow margin: 3.755990156715451%
Revenue growth: 8.90431469675896%
Rule of 40 score: 12.660304853474411
Market cap: 22048681043.392582 (Large Cap ($10B-$200B))
P/E ratio: 8.86201006567226
Debt to equity: 0.41927135178180364
Free cash flow (dilution adjusted): 9270507.00083115
Operating income: 16380026.852503037
Net income: 15906911.322805448
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 8244.T (annual, report date 2026-02-28)
Altman Z-score: 1.6190788043358144 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 19.660570592538402%
Earnings yield: 0.060858943773295066%
Return on net tangible assets: 10.979964067226128%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.437193768373895%
Free cash flow margin: 8.459147070546035%
Revenue growth: 4.89492327376657%
Rule of 40 score: 13.354070344312603
Market cap: 73359233170 (Large Cap ($10B-$200B))
P/E ratio: 19.77870940145592
Debt to equity: 0.04783623944307443
Free cash flow (dilution adjusted): 68086744.51430771
Operating income: 43109200.56460926
Net income: 23796997.30527396
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for CATR.TO (annual, report date 2025-12-31)
Altman Z-score: 4.8981728944576854 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 35.893391701805776%
Earnings yield: 1.9581558911830474%
Return on net tangible assets: 66.24777862401626%
Capitalized R&D asset: 3082079015.8746367
ROCI (R&D adjusted): 16.876898849579955%
Rosenberg metric: -0.4296903959343044
Free cash flow margin: 11.026942253917058%
Revenue growth: 8.856952259379137%
Rule of 40 score: 19.883894513296195
Market cap: 349765368960.46 (Mega Cap (>= $200B))
P/E ratio: 39.37025764975912
Debt to equity: 2.0325546486537194
Free cash flow (dilution adjusted): 5440145985.40146
Operating income: 8139416058.39416
Net income: 6484671532.846715
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for CHKP (annual, report date 2025-12-31)
Altman Z-score: 11.055726537170319 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 39.38489242725808%
Earnings yield: 2.0298603061783718%
Return on net tangible assets: 147.09271870089052%
Capitalized R&D asset: 249733850.87680465
ROCI (R&D adjusted): 13.698724274706137%
Rosenberg metric: 1.183178290499465
Free cash flow margin: 35.488368679826806%
Revenue growth: 21.95753184498632%
Rule of 40 score: 57.445900524813126
Market cap: 60247623791.2272 (Large Cap ($10B-$200B))
P/E ratio: 57.00409101260971
Debt to equity: 0.6842580063148398
Free cash flow (dilution adjusted): 304150943.39622635
Operating income: 261352201.2578616
Net income: 332358490.5660377
Long score: 12 | Short score: 1
Recommendation: Long
Stock screener scorecard for ETD (annual, report date 2025-06-30)
Altman Z-score: 4.408179540707228 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 13.081199513948787%
Earnings yield: 10.474100494042943%
Return on net tangible assets: 15.351064778707627%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.668585942955731%
Free cash flow margin: 7.955922811230474%
Revenue growth: -4.885635100066386%
Rule of 40 score: 3.070287711164088
Market cap: 657787863.1500001 (Small Cap ($300M-$2B))
P/E ratio: 12.748815085471742
Debt to equity: 0.2578560927615086
Free cash flow (dilution adjusted): 48901000
Operating income: 62331000
Net income: 51596000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for GEV.TO (annual, report date 2025-12-31)
Altman Z-score: 3.5976224704448123 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 26.45714285714287%
Earnings yield: 0.391965423403945%
Return on net tangible assets: 74.82122068850823%
Capitalized R&D asset: 1557820529.8351283
ROCI (R&D adjusted): 6.466239095583372%
Rosenberg metric: 1.8126272912423624
Free cash flow margin: 9.745718188504782%
Revenue growth: 13.740408412285992%
Rule of 40 score: 23.486126600790776
Market cap: 236563047684.92 (Mega Cap (>= $200B))
P/E ratio: 48.43633244981982
Debt to equity: 0.09531554977228368
Free cash flow (dilution adjusted): 2708029197.0802917
Operating income: 1013868613.1386861
Net income: 3564963503.649635
Long score: 12 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for QGEN (annual, report date 2025-12-31)
Altman Z-score: 3.374957753678542 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 20.324387077016347%
Earnings yield: 6.407493584028934%
Return on net tangible assets: 60.4251409057035%
Capitalized R&D asset: 428437112.9901961
ROCI (R&D adjusted): 8.571596470653779%
Rosenberg metric: 2.5856871074889693
Free cash flow margin: 18.985655017059816%
Revenue growth: 19.323261225708098%
Rule of 40 score: 38.308916242767914
Market cap: 7813678125 (Mid Cap ($2B-$10B))
P/E ratio: 18.390317560252306
Debt to equity: 0.47969775715865476
Free cash flow (dilution adjusted): 466823529.4117647
Operating income: 612129411.7647059
Net income: 499858823.5294118
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for RCN.L (annual, report date 2025-03-31)
Altman Z-score: 1.159981982766285 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 16.259226299534106%
Earnings yield: 5.492604670774067%
Return on net tangible assets: 86.8377775167391%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.378585663385469%
Free cash flow margin: 12.681111160443399%
Revenue growth: 11.119366151664547%
Rule of 40 score: 23.800477312107944
Market cap: 1975583.3387999998 (Nano Cap (< $50M))
P/E ratio: 0.5663943058486238
Debt to equity: 0.8504882702884725
Free cash flow (dilution adjusted): 22255844.155844156
Operating income: 12101298.7012987
Net income: 4529870.12987013
Long score: 10 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for S32.L (annual, report date 2025-06-30)
Altman Z-score: 0.784841720743082 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 10.886631262987764%
Earnings yield: 5.819550522268388%
Return on net tangible assets: -1.5377500289050752%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.7542965216676265%
Free cash flow margin: 5.397923875432526%
Revenue growth: 15.105965197372873%
Rule of 40 score: 20.5038890728054
Market cap: 126667954.16796578 (Micro Cap ($50M-$300M))
P/E ratio: 0.5946852308355202
Debt to equity: 0.1844868465620413
Free cash flow (dilution adjusted): 203921568.62745097
Operating income: 616339869.2810458
Net income: 139215686.2745098
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for SAM (annual, report date 2025-12-31)
Altman Z-score: 5.320928737079749 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 19.63242776367696%
Earnings yield: 9.597578720713962%
Return on net tangible assets: 20.082253358145643%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.134660771193367%
Free cash flow margin: 9.286904162460576%
Revenue growth: -2.364624974623468%
Rule of 40 score: 6.922279187837108
Market cap: 1628446097.46 (Small Cap ($300M-$2B))
P/E ratio: 15.013009223464769
Debt to equity: 0.04475232783475918
Free cash flow (dilution adjusted): 193841000
Operating income: 151837000
Net income: 108469000
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SLCE3.SA (annual, report date 2025-12-31)
Altman Z-score: 1.2618929324561896 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 13.238359070339087%
Earnings yield: 1.9963747614082612%
Return on net tangible assets: -5.066142122735384%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.887097704820224%
Free cash flow margin: 2.771104312294002%
Revenue growth: 41.03478968186586%
Rule of 40 score: 43.80589399415986
Market cap: 6967925854.985709 (Mid Cap ($2B-$10B))
P/E ratio: 12.327964599161218
Debt to equity: 2.0076508703574527
Free cash flow (dilution adjusted): 49349999.99999999
Operating income: 344368613.1386861
Net income: 103141058.39416057
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SXI (annual, report date 2025-06-30)
Altman Z-score: 3.375284916728668 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 23.337915927898813%
Earnings yield: 2.943542394166593%
Return on net tangible assets: -52.06561751515054%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.706733671213405%
Free cash flow margin: 4.121087397023441%
Revenue growth: 9.640386603481652%
Rule of 40 score: 13.761474000505093
Market cap: 1884960713.98 (Small Cap ($300M-$2B))
P/E ratio: 32.67735791519312
Debt to equity: 0.8162644167714544
Free cash flow (dilution adjusted): 32561000
Operating income: 121886000
Net income: 57684000
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ZDC.V (annual, report date 2025-12-31)
Altman Z-score: 5.223925999288305 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 3.774525645168737%
Earnings yield: 0.4817099305708441%
Return on net tangible assets: -80.3501534763614%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.5972615758258395%
Free cash flow margin: -90.39107852123435%
Revenue growth: 86.39117113991801%
Rule of 40 score: -3.9999073813163335
Market cap: 698844692.7 (Small Cap ($300M-$2B))
P/E ratio: 257.21188542510123
Debt to equity: 0.9282640118233639
Free cash flow (dilution adjusted): -38870802.91970803
Operating income: 2983941.605839416
Net income: 1983211.6788321165
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ZYNS.TO (annual, report date 2025-12-31)
Altman Z-score: 5.466167891302319 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 203.6410745942997%
Earnings yield: 3.242099356012669%
Return on net tangible assets: -32.18237113942635%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 34.12633118515472%
Free cash flow margin: 11.361723436218156%
Revenue growth: 9.535462638707223%
Rule of 40 score: 20.89718607492538
Market cap: 347377076862.64 (Mega Cap (>= $200B))
P/E ratio: 29.31946968793383
Debt to equity: -6.083084205281514
Free cash flow (dilution adjusted): 7783941605.839416
Operating income: 10900000000
Net income: 8648175182.48175
Long score: 9 | Short score: 4
Recommendation: Long
Stock screener scorecard for 0031.HK (annual, report date 2025-12-31)
Altman Z-score: 1.2125609729369278 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.9182950984037817%
Earnings yield: 0.30952303672334613%
Return on net tangible assets: -7.812835204150674%
Capitalized R&D asset: 47489019.72406751
ROCI (R&D adjusted): 0.7638572152077041%
Rosenberg metric: -0.6666485402469348
Free cash flow margin: -9.34401533588551%
Revenue growth: 4.672523615304784%
Rule of 40 score: -4.671491720580726
Market cap: 1511660800 (Small Cap ($300M-$2B))
Debt to equity: 0.20850000000000002
Free cash flow (dilution adjusted): -48417480.71979434
Operating income: 11941902.313624678
Net income: -21276221.079691514
Long score: 2 | Short score: 12
Recommendation: Short
Stock screener scorecard for 0696.HK (annual, report date 2025-12-31)
Altman Z-score: 3.428205109736736 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 12.110875733824441%
Earnings yield: 2.446627380969508%
Return on net tangible assets: 8.179628246506521%
Capitalized R&D asset: 186796997.00441527
ROCI (R&D adjusted): 8.168408944690498%
Rosenberg metric: -0.19281205075417734
Free cash flow margin: 23.736966453691103%
Revenue growth: -0.9035171502935431%
Rule of 40 score: 22.83344930339756
Market cap: 24667947008 (Large Cap ($10B-$200B))
P/E ratio: 1.3655084722337396
Debt to equity: 0.0837
Free cash flow (dilution adjusted): 267447881.80205655
Operating income: 300975560.3071979
Net income: 309242120.1503856
Long score: 8 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 1199.HK (annual, report date 2025-12-31)
Altman Z-score: 3.0393583680781844 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.511619084724735%
Earnings yield: 0.11648615026769772%
Return on net tangible assets: 8.368727884663297%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.009448427107045%
Free cash flow margin: 24.76577530366677%
Revenue growth: 10.76105466283013%
Rule of 40 score: 35.526829966496905
Market cap: 20605726720 (Large Cap ($10B-$200B))
P/E ratio: 1.0985700514138816
Debt to equity: 0.5303
Free cash flow (dilution adjusted): 53129177.37789203
Operating income: 28279820.051413883
Net income: 49640488.43187661
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 1766.HK (quarterly, report date 2026-03-31)
Altman Z-score: 0.7534196016252881 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 3.8389520074134063%
Earnings yield: 0.546345741877911%
Return on net tangible assets: 1.6627537325918231%
Capitalized R&D asset: 1133056391.2466407
ROCI (R&D adjusted): 2.033789221067327%
Rosenberg metric: -0.91327704959134
Free cash flow margin: -19.620912541374906%
Revenue growth: -38.87809778168349%
Rule of 40 score: -58.4990103230584
Market cap: 140624429056 (Large Cap ($10B-$200B))
P/E ratio: 1.1668556311413454
Debt to equity: 0.08900000000000001
Free cash flow (dilution adjusted): -1528175397.9739509
Operating income: 752037192.4746743
Net income: 584991172.2141824
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1787.HK (quarterly, report date 2026-03-31)
Altman Z-score: 0.6714923696070425 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 12.889580721020927%
Earnings yield: 0.39604351834774426%
Capitalized R&D asset: 62700544.17936568
ROCI (R&D adjusted): 4.09464097592786%
Rosenberg metric: -0.5095396928888485
Free cash flow margin: 10.343985242065525%
Revenue growth: 60.64736373069651%
Rule of 40 score: 70.99134897276204
Market cap: 89985826816 (Large Cap ($10B-$200B))
P/E ratio: 3.4245841193620303
Debt to equity: 1.0047
Free cash flow (dilution adjusted): 486750779.6324168
Operating income: 609341906.6107091
Net income: 352972160.7206946
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1789.HK (annual, report date 2025-12-31)
Altman Z-score: 6.787682980346402 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 13.940987577352567%
Earnings yield: 1.080353756739281%
Return on net tangible assets: 12.83862318627971%
Capitalized R&D asset: 38572367.55761434
ROCI (R&D adjusted): 11.452980956389283%
Rosenberg metric: 0.9170710006342092
Free cash flow margin: 17.833448796206792%
Revenue growth: 14.824607075135704%
Rule of 40 score: 32.6580558713425
Market cap: 5817825280 (Mid Cap ($2B-$10B))
P/E ratio: 2.0455380095482925
Debt to equity: 0.0297
Free cash flow (dilution adjusted): 37767142.85714286
Operating income: 53411428.571428575
Net income: 48442000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1942.T (annual, report date 2026-03-31)
Altman Z-score: 5.875144413526448 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 25.084932928632202%
Earnings yield: 0.04568930182188762%
Return on net tangible assets: 16.258196615089552%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.401985447519127%
Free cash flow margin: 9.928277059170753%
Revenue growth: 3.3770361504671262%
Rule of 40 score: 13.30531320963788
Market cap: 1188909285376 (Mega Cap (>= $200B))
P/E ratio: 0.11760574068167708
Debt to equity: 0.0347
Free cash flow (dilution adjusted): 460898398.3983984
Operating income: 520151401.4014014
Net income: 412356106.1061061
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 2865.HK (quarterly, report date 2026-03-31)
Altman Z-score: 0.3530201253323895 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.829248516482988%
Earnings yield: 0.4486501738324906%
Return on net tangible assets: -0.40560234494747766%
Capitalized R&D asset: 5736080.595528295
ROCI (R&D adjusted): 2.2554540600919157%
Rosenberg metric: 22.840720726234807
Free cash flow margin: -42.992499459268636%
Revenue growth: -11.779589753995074%
Rule of 40 score: -54.77208921326371
Market cap: 5008270848 (Mid Cap ($2B-$10B))
P/E ratio: 34.77243247147992
Debt to equity: 1.4711
Free cash flow (dilution adjusted): -105414582.29956585
Operating income: 31113673.916063674
Net income: 2049725.9030390738
Long score: 2 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for 5715.T (annual, report date 2026-03-31)
Altman Z-score: 2.210870578786201 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 6.881747931091178%
Earnings yield: 0.04507740109857183%
Return on net tangible assets: 8.989215392576051%
Capitalized R&D asset: 13453445.333473336
ROCI (R&D adjusted): 4.999334188595794%
Rosenberg metric: 0.601542809407978
Free cash flow margin: -0.6912038506544881%
Revenue growth: -1.8046751601116042%
Rule of 40 score: -2.4958790107660924
Market cap: 116105674752 (Large Cap ($10B-$200B))
P/E ratio: 0.06923553374696448
Debt to equity: 0.39159999999999995
Free cash flow (dilution adjusted): -9127877.877877878
Operating income: 70701951.95195195
Net income: 80887137.13713713
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6033.T (annual, report date 2026-03-31)
Altman Z-score: 5.645422265243777 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 34.24033892194321%
Earnings yield: 0.16215113863338662%
Return on net tangible assets: 18.926452906885686%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.85986245846663%
Free cash flow margin: 6.328899950916023%
Revenue growth: -2.596798088390612%
Rule of 40 score: 3.732101862525411
Market cap: 9103003648 (Mid Cap ($2B-$10B))
P/E ratio: 0.04124159644836593
Debt to equity: 0.08990000000000001
Free cash flow (dilution adjusted): 4670695.6956956955
Operating income: 9007501.25125125
Net income: 7581268.768768769
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 7970.T (annual, report date 2026-03-31)
Altman Z-score: 7.215790860204419 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 10.846240006179753%
Earnings yield: 0.06703944308460645%
Return on net tangible assets: 9.471935150748111%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.554365392565867%
Free cash flow margin: 8.871051808610444%
Revenue growth: -2.555926728486454%
Rule of 40 score: 6.315125080123989
Market cap: 181398978560 (Large Cap ($10B-$200B))
P/E ratio: 0.09819350945812157
Debt to equity: 0
Free cash flow (dilution adjusted): 63888888.88888889
Operating income: 87844094.0940941
Net income: 61930680.68068068
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 9869.HK (annual, report date 2025-12-31)
Altman Z-score: 4.811853574534682 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.326054563812997%
Earnings yield: 0.22376661654637406%
Return on net tangible assets: 10.65831581185881%
Capitalized R&D asset: 1489726.3593351333
ROCI (R&D adjusted): 2.9412735877649716%
Rosenberg metric: -13.323781676413262
Free cash flow margin: 23.293488605941643%
Revenue growth: -25.271882208559127%
Rule of 40 score: -1.9783936026174835
Market cap: 2340254720 (Mid Cap ($2B-$10B))
P/E ratio: 3.684661525278492
Debt to equity: 0.1628
Free cash flow (dilution adjusted): 17936285.714285713
Operating income: 3877571.4285714286
Net income: 4850571.428571428
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 9908.T (annual, report date 2026-03-31)
Altman Z-score: 3.225541204183804 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 14.73782762876898%
Earnings yield: 0.0771559821619558%
Return on net tangible assets: 12.44597849270474%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.462163658979645%
Free cash flow margin: -2.922704068261443%
Revenue growth: 2.804328655210246%
Rule of 40 score: -0.11837541305119714
Market cap: 29711056896 (Large Cap ($10B-$200B))
P/E ratio: 0.04703248918626826
Debt to equity: 0.5448
Free cash flow (dilution adjusted): -24346458.958958957
Operating income: 31108533.533533532
Net income: 22843937.687687688
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ATMU (quarterly, report date 2026-03-31)
Altman Z-score: 2.9448291772985487 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 9.002751932905255%
Earnings yield: 1.3151156766407448%
Return on net tangible assets: -42.31111111111111%
Capitalized R&D asset: 18703000
ROCI (R&D adjusted): 4.475844993531804%
Rosenberg metric: 0.8623853211009175
Free cash flow margin: 4.628272251308901%
Revenue growth: 6.918943125839677%
Rule of 40 score: 11.547215377148579
Market cap: 4374375424 (Mid Cap ($2B-$10B))
P/E ratio: 22.239215686274513
Debt to equity: 2.6248
Free cash flow (dilution adjusted): 22100000
Operating income: 68700000
Net income: 48400000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for CCJ (quarterly, report date 2026-03-31)
Altman Z-score: 11.329427907924455 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 3.369585990562581%
Earnings yield: 0.3094071255679066%
Return on net tangible assets: 1.7086839595477694%
Capitalized R&D asset: 19735449.509005938
ROCI (R&D adjusted): 1.7536516032937741%
Rosenberg metric: 1.6395722534037729
Free cash flow margin: -12.168708191136373%
Revenue growth: -30.620313022395635%
Rule of 40 score: -42.78902121353201
Market cap: 38265929728 (Large Cap ($10B-$200B))
P/E ratio: 103.43809523809523
Debt to equity: 0.1431
Free cash flow (dilution adjusted): -74007194.24460433
Operating income: 118092086.33093525
Net income: 94065467.62589929
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for G4M.L (annual, report date 2026-03-31)
Altman Z-score: 4.048369370133668 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 23.78739599929191%
Earnings yield: 20.315892281548408%
Return on net tangible assets: 54.53975714845279%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.298003305083462%
Free cash flow margin: 2.3870815529399425%
Revenue growth: 31.709835777420665%
Rule of 40 score: 34.096917330360604
Market cap: 58211004 (Micro Cap ($50M-$300M))
P/E ratio: 0.08496240601503759
Debt to equity: 0.41960000000000003
Free cash flow (dilution adjusted): 5990789.47368421
Operating income: 14144736.842105264
Net income: 9625000
Long score: 16 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for IMG.TO (quarterly, report date 2026-03-31)
Altman Z-score: 5.432355761734282 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 10.818916717977237%
Earnings yield: 3.2296627935945255%
Return on net tangible assets: 12.243626715884185%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.95849863795089%
Free cash flow margin: 44.53936511018348%
Revenue growth: -6.69254505411385%
Rule of 40 score: 37.84682005606963
Market cap: 11941479424 (Large Cap ($10B-$200B))
P/E ratio: 7.809188333980118
Debt to equity: 0.1471
Free cash flow (dilution adjusted): 330071942.4460432
Operating income: 391870503.5971223
Net income: 300287769.78417265
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for INDRAMEDCO.NS (annual, report date 2026-03-31)
Altman Z-score: 10.527854581024398 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 36.348097865898325%
Earnings yield: 0.07596527143929649%
Return on net tangible assets: 22.647730497412265%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 27.17051386573539%
Free cash flow margin: 7.270777262885241%
Revenue growth: -0.9158994053992983%
Rule of 40 score: 6.354877857485943
Market cap: 33423976448 (Large Cap ($10B-$200B))
P/E ratio: 0.19623233908948196
Debt to equity: 0.049800000000000004
Free cash flow (dilution adjusted): 11423272.573124206
Operating income: 23663628.65621026
Net income: 19459516.744383212
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for INDRAMEDCO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 8.820809713367845 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 8.004102163402843%
Earnings yield: 0.016728077373237532%
Return on net tangible assets: 7.167277002283691%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.983134787846339%
Revenue growth: -6.605213176001834%
Rule of 40 score: -6.605213176001834
Market cap: 33423976448 (Large Cap ($10B-$200B))
P/E ratio: 0.19623233908948196
Debt to equity: 0.049800000000000004
Operating income: 5210894.4467994915
Net income: 4419245.442984316
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ITH.L (quarterly, report date 2025-12-31)
Altman Z-score: 0.774782868076302 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.4571189004939757%
Earnings yield: 6.598093020831073%
Return on net tangible assets: -0.23519870235198634%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.856607444282322%
Free cash flow margin: 24.362997364127022%
Revenue growth: 14.517751904556556%
Rule of 40 score: 38.88074926868358
Market cap: 4251945472 (Mid Cap ($2B-$10B))
P/E ratio: 0.18863999348571428
Debt to equity: 0.696
Free cash flow (dilution adjusted): 262297297.2972973
Operating income: 364324324.3243243
Net income: 47297297.2972973
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ITH.L (annual, report date 2025-12-31)
Altman Z-score: 1.3384646485900937 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 9.669893002314943%
Earnings yield: 25.966530768181638%
Return on net tangible assets: -10.364963503649632%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.17752410379653%
Free cash flow margin: 28.969964364500257%
Revenue growth: 60.73294002449315%
Rule of 40 score: 89.7029043889934
Market cap: 4251945472 (Mid Cap ($2B-$10B))
Debt to equity: 0.696
Free cash flow (dilution adjusted): 1153513513.5135136
Operating income: 1433783783.783784
Net income: -113648648.64864865
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MCM.MC (annual, report date 2025-12-31)
Altman Z-score: 4.288232728730055 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.258708320615174%
Earnings yield: 11.876617451048537%
Return on net tangible assets: 16.017547854942404%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.117795405872423%
Free cash flow margin: 3.8191313435784364%
Revenue growth: 14.647513551463204%
Rule of 40 score: 18.46664489504164
Market cap: 526616640 (Small Cap ($300M-$2B))
P/E ratio: 14.11764705882353
Debt to equity: 0.1155
Free cash flow (dilution adjusted): 14101176.470588235
Operating income: 64104705.88235294
Net income: 53030588.23529412
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for MOIL.NS (annual, report date 2026-03-31)
Altman Z-score: 7.674459664517185 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 10.309034747447795%
Earnings yield: 0.054667380668747906%
Return on net tangible assets: 4.299878750856146%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.922686913162654%
Free cash flow margin: -11.44294736516204%
Revenue growth: -15.759045180943659%
Rule of 40 score: -27.2019925461057
Market cap: 54707003392 (Large Cap ($10B-$200B))
P/E ratio: 0.22726233334429863
Debt to equity: 0
Free cash flow (dilution adjusted): -17860968.630775753
Operating income: 25942740.568037305
Net income: 28346725.307333615
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MOIL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 7.195308338488671 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.830610655955863%
Earnings yield: 0.020313196730154075%
Return on net tangible assets: 3.571643434960478%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.3154742812153732%
Revenue growth: 17.491934137263605%
Rule of 40 score: 17.491934137263605
Market cap: 54707003392 (Large Cap ($10B-$200B))
P/E ratio: 0.22726233334429863
Debt to equity: 0
Operating income: 9639752.01356507
Net income: 9814857.990674015
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PRIM (quarterly, report date 2026-03-31)
Altman Z-score: 2.1049014497110465 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 1.936737702720815%
Earnings yield: 0.5494197908001677%
Return on net tangible assets: 2.0904836193447736%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.136497699476975%
Free cash flow margin: -10.135265081094943%
Revenue growth: -16.027004432012774%
Rule of 40 score: -26.162269513107717
Market cap: 4693594624 (Mid Cap ($2B-$10B))
P/E ratio: 31.54966887417218
Debt to equity: 0.5511
Free cash flow (dilution adjusted): -158100000
Operating income: 28900000
Net income: 17400000
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for ROHLTD.NS (annual, report date 2026-03-31)
Altman Z-score: 1.2415083712633361 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 7.0564781813017685%
Earnings yield: 0.03903169214940882%
Return on net tangible assets: 16.11415944118804%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.89117206004328%
Free cash flow margin: 13.551017114386157%
Revenue growth: 9.006491816262571%
Rule of 40 score: 22.55750893064873
Market cap: 8527871488 (Mid Cap ($2B-$10B))
P/E ratio: 0.2436100622718681
Debt to equity: 2.3251
Free cash flow (dilution adjusted): 5516776.176345909
Operating income: 5589709.622721492
Net income: 3531941.500635863
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ROHLTD.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.8591098920056357 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 1.893687987658505%
Earnings yield: 0.010474608531657747%
Return on net tangible assets: 8.168484220470212%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.580964537365765%
Revenue growth: -4.741206215544563%
Rule of 40 score: -4.741206215544563
Market cap: 8527871488 (Mid Cap ($2B-$10B))
P/E ratio: 0.2436100622718681
Debt to equity: 2.3251
Operating income: 1500063.5862653668
Net income: 870983.4675710046
Long score: 0 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SCI.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.2541242519054885 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.295436790961644%
Earnings yield: 0.022868624513379857%
Return on net tangible assets: 4.4481775225212346%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.9103283415196213%
Revenue growth: -10.676367994122192%
Rule of 40 score: -10.676367994122192
Market cap: 128141312000 (Large Cap ($10B-$200B))
P/E ratio: 0.07979344502478608
Debt to equity: 0.2945
Operating income: 34423484.527342096
Net income: 42878338.27893175
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for SCI.NS (annual, report date 2026-03-31)
Altman Z-score: 2.7719067349178395 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.379513953002334%
Earnings yield: 0.0789679330065494%
Return on net tangible assets: 10.114381707721977%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.04969115504608%
Free cash flow margin: -3.585424383930904%
Revenue growth: -6.534044614881661%
Rule of 40 score: -10.119468998812565
Market cap: 128141312000 (Large Cap ($10B-$200B))
P/E ratio: 0.07979344502478608
Debt to equity: 0.2945
Free cash flow (dilution adjusted): -21961636.286562104
Operating income: 118868164.47647308
Net income: 143378550.23314965
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for VIAV (quarterly, report date 2026-03-31)
Altman Z-score: -34.7290301248822 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 6.3251201923076925%
Earnings yield: 0.4261246003522114%
Return on net tangible assets: -12.31741018555073%
Capitalized R&D asset: 133633000
ROCI (R&D adjusted): 2.429150200628891%
Rosenberg metric: 0.3566009104704097
Free cash flow margin: -11.332350049164209%
Revenue growth: 10.154346060113728%
Rule of 40 score: -1.178003989050481
Market cap: 9749016576 (Mid Cap ($2B-$10B))
P/E ratio: 320.69134110000005
Debt to equity: 1.3426
Free cash flow (dilution adjusted): -46100000
Operating income: 42100000
Net income: 6400000
Long score: 1 | Short score: 11
Recommendation: Short
Stock screener scorecard for WBD (quarterly, report date 2026-03-31)
Altman Z-score: 0.45378825260957484 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 24.206349206349206%
Earnings yield: 0.5784554349861063%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.6717897261447346%
Free cash flow margin: -7.061733948049027%
Revenue growth: -5.993657505285412%
Rule of 40 score: -13.05539145333444
Market cap: 64608915456 (Large Cap ($10B-$200B))
Debt to equity: 0.9632
Free cash flow (dilution adjusted): -628000000
Operating income: 549000000
Net income: -2906000000
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1766.HK (annual, report date 2025-12-31)
Altman Z-score: 1.0129162027973142 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 14.680825487834179%
Earnings yield: 2.031433030388326%
Return on net tangible assets: 11.21373508133746%
Capitalized R&D asset: 4649491675.695047
ROCI (R&D adjusted): 7.83511920192778%
Rosenberg metric: 0.513377893140545
Free cash flow margin: 5.4211649645899795%
Revenue growth: 15.53565599872528%
Rule of 40 score: 20.95682096331526
Market cap: 22653134027.352184 (Large Cap ($10B-$200B))
P/E ratio: 1.3407748587203585
Debt to equity: 0.10050581154534118
Free cash flow (dilution adjusted): 2114743000
Operating income: 2796238857.142857
Net income: 2413650571.428571
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1787.HK (annual, report date 2025-12-31)
Altman Z-score: 0.9447713820033894 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 14.710387834509595%
Earnings yield: 1.3358715899679174%
Return on net tangible assets: 3.1553793490923967%
Capitalized R&D asset: 235163016.77691233
ROCI (R&D adjusted): 14.651732893766653%
Rosenberg metric: 11.20992053840549
Free cash flow margin: 8.212165156738099%
Revenue growth: 31.79774078233983%
Rule of 40 score: 40.009905939077925
Market cap: 30569614753.98201 (Large Cap ($10B-$200B))
P/E ratio: 4.6129629286828955
Debt to equity: 1.0183806488017457
Free cash flow (dilution adjusted): 1223464690.637143
Operating income: 2055336102.9971428
Net income: 946699093.2971429
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2189.HK (annual, report date 2025-03-31)
Altman Z-score: 1.8571252861906786 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 17.55180886400823%
Earnings yield: 1.1634420539453663%
Return on net tangible assets: 11.822754842003798%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.9165157367857%
Free cash flow margin: 21.824328159589296%
Revenue growth: 17.62330106513825%
Rule of 40 score: 39.44762922472755
Market cap: 450000000.00000006 (Small Cap ($300M-$2B))
P/E ratio: 20.562968378724186
Debt to equity: 0.7529147860379714
Free cash flow (dilution adjusted): 8895629.820051413
Operating income: 8245244.215938303
Net income: 2812853.4704370177
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 7849.T (annual, report date 2025-12-31)
Altman Z-score: 6.869765983015439 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 20.54488469967702%
Earnings yield: 0.18547358254113017%
Return on net tangible assets: 13.55114332922677%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.927932508394838%
Free cash flow margin: 8.957572463576797%
Revenue growth: -4.753886766988414%
Rule of 40 score: 4.2036856965883835
Market cap: 14285715005.177208 (Large Cap ($10B-$200B))
P/E ratio: 10.372614911840603
Debt to equity: 0
Free cash flow (dilution adjusted): 4663691.579822262
Operating income: 11232338.085800141
Net income: 8805402.467872899
Long score: 9 | Short score: 1
Recommendation: Long